8/9/24 16:30 | 8/7/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | S.m | -61 | 0.1899 | 0 | -322 | -5 | 6,318 | D | | | | | | | | | | | | | | |
8/7/24 16:30 | 8/5/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | S.m | -41 | 0.1870 | 0 | -220 | -3 | 6,640 | D | | | | | | | | | | | | | | |
8/5/24 16:53 | 8/1/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | S.m | -71 | 0.2033 | 0 | -350 | -5 | 6,860 | D | | | | | | | | | | | | | | |
7/30/24 17:16 | 7/26/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | S.m | -315 | 0.2286 | 0 | -1,379 | -16 | 7,210 | D | | | | | | | | | | | | | | |
6/24/24 16:29 | 6/20/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 79 | 0.2584 | 0 | 305 | 81 | 680 | D | | | | | | | | | | | | | | |
6/20/24 16:15 | 6/18/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | P | 4 | 0.2477 | 0 | 18 | 33 | 71 | D | | | | | | | | | | | | | | |
9/25/23 16:21 | 9/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 90 | 1.38 | 0 | 65 | 21 | 375 | D | | | | | | | | | | | | | | |
6/2/23 16:10 | 6/1/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | D | | M.d | 13 | 0.6000 | 0 | 21 | 133 | 37 | D | | | | | | | | | | | | | | |
5/18/23 16:27 | 5/17/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | S | -7 | 1.95 | 0 | -4 | -7 | 53 | D | | | | | | | | | | | | | | |
5/11/23 17:08 | 5/10/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 47 | 1.56 | 0 | 30 | 47 | 93 | D | | | | | | | | | | | | | | |
5/9/23 17:00 | 5/8/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Johnson Bruce S | MD | O | SVP,Chie | P | 21 | 1.57 | 0 | 14 | 11 | 139 | D | | | | | | | | | | | | | | |
2/23/23 18:23 | 2/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P.m | 712 | 1.78 | 0 | 400 | 5 | 8,489 | D | | | | | | | | | | | | | | |
2/17/23 17:29 | 2/15/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P.m | 3,028 | 2.00 | 0 | 1,515 | 23 | 8,089 | D | | | | | | | | | | | | | | |
2/13/23 17:45 | 2/9/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P | 37 | 3.24 | 0 | 11 | 0 | 6,574 | D | | | | | | | | | | | | | | |
1/30/23 16:13 | 1/27/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | D | | M.d | 27 | 2.55 | 0 | 11 | 200 | 16 | D | | | | | | | | | | | | | | |
1/27/23 17:15 | 1/25/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S.m | -11,485 | 3.14 | 0 | -3,652 | -42 | 4,968 | I | | | | | | | | | | | | | | |
1/6/23 18:35 | 1/5/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S | -197 | 2.76 | 0 | -71 | -1 | 8,620 | I | | | | | | | | | | | | | | |
1/4/23 17:26 | 12/30/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S.m | -1,186 | 2.98 | 0 | -398 | -4 | 8,691 | I | | | | | | | | | | | | | | |
12/27/22 18:41 | 12/22/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P | 248 | 2.25 | 0 | 110 | 55 | 310 | D | | | | | | | | | | | | | | |
11/18/22 16:01 | 11/17/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 37 | 1.87 | 0 | 20 | 46 | 63 | D | | | | | | | | | | | | | | |
11/16/22 16:26 | 11/14/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 309 | 1.55 | 0 | 200 | New | 200 | D | | | | | | | | | | | | | | |
11/14/22 16:14 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Pearson Timothy R | MD | D | | P | 25 | 1.29 | 0 | 19 | 370 | 25 | D | | | | | | | | | | | | | | |
11/14/22 16:13 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Semerjian Harout | MD | DO | CEO | P | 32 | 1.29 | 0 | 25 | New | 25 | D | | | | | | | | | | | | | | |
11/14/22 16:13 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | P | 21 | 1.06 | 0 | 20 | 54 | 57 | D | | | | | | | | | | | | | | |
11/14/22 16:11 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | O | SVP of R | P | 53 | 1.17 | 0 | 45 | 14 | 371 | D | | | | | | | | | | | | | | |
11/14/22 16:04 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Girard Armand | MD | O | SVP,Chie | P | 7 | 1.05 | 0 | 7 | 29 | 29 | D | | | | | | | | | | | | | | |